We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
EditorialFree Access

Can regular intercourse preserve sexual function in the aging male?

    Duane R Hickling

    Division of Urology, Department of Surgery, University of Ottawa, Canada

    ,
    Ronald G Gerridzen

    Division of Urology, Department of Surgery, University of Ottawa, Canada

    &
    Anthony J Bella

    † Author for correspondence

    Division of Urology, Department of Surgery and, Department of Neuroscience, Ottawa Health Research Institute, University of Ottawa, Canada.

    Published Online:https://doi.org/10.2217/1745509X.4.5.509

    The relationship between erectile dysfunction (ED) and increasing age, with a reported prevalence of 40% at 40 years of age, compared with 70% or more by 70 years of age, is well documented through several well-designed epidemiological studies; for severe ED, rates triple from 5 to 15% for men aged 40 years compared with those aged 70 years [1–2]. Studies consistently demonstrate a steep age-related increase; the primary consideration is accumulation of risk factors for ED, not chronological age itself [2]. Although historical estimates for the prevalence of ED may vary from one report to another, this is explained by the methodology design of the different surveys and the influence of contemporary validated metrics, such as the International Index of Erectile Function (IIEF; introduced in 1998) and minor changes in the definition of ED [2].

    Koskimaki et al. recently reported data from the Tampere Aging Male Urologic Study and concluded that regular intercourse protects against the development of ED among men aged 55 to 75 years [3]. Given the potential wide-ranging impact on general health and quality of life, the authors emphasize that healthcare providers should support patients’ sexual activity.

    Impact of erectile dysfunction on the aging male

    Although more than 70% of men over 65 years are sexually active, 40% are dissatisfied with their sex life [4,5]. In one large, multinational survey, less than 25% of men and women felt that ‘older people no longer want sex’, and over 60% of men and women supported the idea of using medical treatments to aid in sexual enjoyment [6]. Increasing longevity of women and men, recognition of sexual health as an integral part of general health, and the development of a variety of treatments aimed at improvement of sexual function have contributed to a change in the attitude of aging men, their partners and the medical community [7].

    Sexual health is determined by interactions between biological, psychological and sociocultural factors of the individual partners and their sexual and intimate interaction in the relationship with their partner(s). ED may increase personal vulnerability, performance anxiety and distress, thus effecting interpersonal relationships on several levels, including avoidance of intimacy but also diminished day-to-day quality of life, including increased worry and lowered self-esteem [7–10]. Men and women who rate their health as being poor are less likely to be sexually active and more likely to report sexual problems; however, the proportion of men or women with sexual dysfunction accessing sexual healthcare expertise remains low, as only 38% of men and 22% of women in a recent study by Tressel Lindau et al. reported having discussed sex with a physician since the 50 years of age [11].

    Risk factors for erectile dysfunction

    A wide variety of common medical conditions and medications may lead to deterioration in sexual function, and ED may be the first symptom of a variety of systemic conditions including early (presymptomatic) cardiovascular disease (CVD) [12]. The fact that new-onset ED is a harbinger of cardiovascular clinical events (hazard ratio 1.25; 95% CI: 1.02–1.53; p = 0.04) in some men should prompt the clinician to perform a thorough investigation for CVD risk factors if ED is identified; current limitations of screening for ED as part of general patient evaluation limits intervention for all patients in this at-risk population [12].

    While relational, psychologic and organic issues are important contributors to ED across age groups, organic issues tend to play a more pronounced role as men age [13,14]. Common risk factors between generalized penile arterial insufficiency and CVD include hypertension, hyperlipidemia, cigarette smoking, diabetes mellitus and central obesity/sedentary lifestyle; ED may also be the first manifestation of many disease states, including metabolic syndrome, spinal-cord compression, pituitary tumors and pelvic malignancies [15]. Men with angina, myocardial infarction or heart failure may also have ED from anxiety or depression. Many commonly used medications, including antihypertensives and antidepressants, cause or exacerbate ED and these results are reported elsewhere [2,11,14].

    Aging is associated with changes in hormone levels, including decreased testosterone and increased sex hormone-binding globulin. Although testosterone levels do not correspond to severity of ED, in patients with reduced libido lower levels of testosterone are observed [15]. Even though erections in response to visual sexual stimulation are preserved in men with hypogonadism, and normal androgen levels are not absolutely essential for erectile function, evaluation and correction of hormonal abnormalities, especially with phosphodiesterase type 5-inhibitor nonresponders, is warranted since a high rate of satisfactory response (treatment salvage) is noted [2].

    Finally, social drugs including cigarettes and excess use of alcohol also affect erectile function. Cigarette smoking may actively induce vasoconstriction, penile venous leak ED owing to its contractile effect on the cavernous smooth muscle, or accelerate atherosclerotic changes in penile microvaculature [15]. Lifestyle modification remains a key treatment option or adjunct for most men with ED.

    Tampere Aging Male Urologic Study

    In a study sample of 989 men aged 55–75 years (mean 59.2 years) followed for 5 years, and after adjusting for comorbidity and other major risk factors, men reporting an intercourse frequency less than once per week at baseline demonstrated twice the incidence of ED versus men reporting an intercourse frequency once per week or more (79 vs 33 per 1000; incidence rate ratio 2.2; 95% CI: 1.3–3.8) [3]. Controlled variables included cardiovascular disease, diabetes, hypertension, body mass index, depression and smoking.

    Could it be that regular sexual activity functions in a similar fashion as physical function, in this case, preserving the ability to attain and maintain erections? Erectile function is dependent on intact physiologic response to stimulation, including vascular and penile smooth muscle components; of course, this is a simplified overview by necessity but underscores the importance of maintaining ‘penile health’. Just as regular exercise regimens are key to maintaining cardiovascular health, general fitness and enhanced quality of life, ‘signals’ in peer-reviewed literature support a similar paradigm for erectile function including preservation of vascular function, maintained cavernosal reactivity, and prevention of cavernous fibrosis [3]. Montorsi et al. recently reported a study of men with ED following bilateral nerve-sparing radical prostatectomy for which placebo-group patients (double-blind design) attempted intercourse on a weekly basis throughout recovery [16]. In comparison to historical results and patients treated with a phosphodiesterase type 5 inhibitor, this group demonstrated a higher rate of erectile function recovery than expected, part of which has been attributed to the active penile physiotherapy that attempts at intercourse provide. The oft-quoted proverb ‘use it or lose it’ seems justified, but not only from a purely anatomic or physiologic standpoint; continued intimacy and nurturing of the interpersonal relationship, as provided by a healthy sexual component, also protects against the psychosocial decline in interest and sexuality that may occur with time [6–8].

    Conclusion

    Normal aging does not necessarily mean healthy aging [17]. Koskimaki and colleagues have provided a valuable contribution to the literature concerning aging and male sexual function, and support the notion that healthcare providers bear a responsibility to evaluate the quality of sexual function in the aging male as part of comprehensive patient care. Regular sexual activity seems to preserve potency in a similar fashion to physical exercise maintaining functional capacity [3]. Not only does increased coital frequency decrease the incidence of ED, but it may also benefit the mutually interested patient and partner psychologically, and improves quality of life in many instances.

    Financial & competing interests disclosure

    The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

    No writing assistance was utilized in the production of this manuscript.

    Bibliography

    • Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol.151(1),54–61 (1994).
    • Hackett G, Kell P, Ralph D et al.: British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction. J. Sex. Med.5,1841–1865 (2008).
    • Koskimaki J, Shiri R, TammelaT, Hakkinen J, Hakama M, Auvinen A: Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am. J. Med.121,592–596 (2008).
    • Rosen R, Altwein J, Boyle P et al.: Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur. Urol.44(6),637–649 (2003).
    • Araujo AB, Mohr BA, McKinlay JB: Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J. Am. Geriatr. Soc.52(9),1502–1509 (2004).
    • Nicolosi A, Laumann EO, Glasser DB et al.: Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology64(5),991–997 (2004).
    • Bitzer J, Platano G, Tschudin S, Alder J: Sexual counselling in elderly couples. J. Sex. Med. DOI: 10.1111/j.1743-6109.2008.00926.x (2008) (Epub ahead of print).
    • Gralla O, Knoll N, Fenske S et al.: Worry, desire, and sexual satisfaction and their association with severity of ED and age. J. Sex. Med. DOI: 10.1111/j.1743-6109.2008.00842.x (2008) (Epub ahead of print).
    • McCabe MP: Relationship factors in the development and maintainence of ED: Implications for treatment effectiveness. J. Sex. Med. DOI: 10.1111/j.1743-6109.2008.00878.x (2008) (Epub ahead of print).
    • 10  Melnik T, Soares BG, Nasello AG: The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernous injection, and vacuum devices. J. Sex. Med. DOI: 10.1111/j.1743-6109. 2008.00872.x (2008) (Epub ahead of print).
    • 11  Tressel Lindau S, Schumm LP, Laumann EO, Lewinson W, Muircheartaigh CA, Waite LJ: A study of sexuality and health among older adults in the United States. N. Engl. J. Med.357,762–774 (2007).
    • 12  Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA: Erectile dysfunction and subsequent cardiovascular disease. JAMA294(23),2996–3002 (2005).
    • 13  Shabsigh R, Shah M, Sand M: Erectile dysfunction and men's health: developing a comorbidity risk calculator. J. Sex. Med.5(5),1237–1243 (2008).
    • 14  Baumgartner MK, Hermanns T, Cohen A et al.: Patients’ knowledge about risk factors for erectile dysfunction. J. Sex. Med. DOI: 10.1111/j.1743-6109.2008.00866.x (2008) (Epub ahead of print).
    • 15  Brant WO, Bella AJ, Lue TF: Erectile and sexual dysfunction in the aging diabetic male. Aging Health2(6),1025–1034 (2006).
    • 16  Montorsi F, Brock G, Lee J et al.: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur. Urol. DOI: 10.1016/j.eururo.2008.06.083 (2008) (Epub ahead of print).
    • 17  Korfarge IJ, Roobol M, de Koning HJ, Kirkels WJ, Schroder FH, Essink-Bot M-L: Does ‘normal’ aging imply urinary, bowel, and erectile dysfunction? A general population survey. Urology72(1),3–9 (2008).